Mark Neumann - EVP, Chief Commercial Officer at Intra-Cellular Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial Officer
Stock Symbol
ITCI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Neumann since 11/21/2024

Holdings reported by Mark Neumann for Intra-Cellular Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $132.00 Apr 2, 2025 Direct
Performance Stock Units 0 $0 $132.00 Apr 2, 2025 Direct Common Stock
Restricted Stock Units 0 $0 $132.00 Apr 2, 2025 Direct Common Stock
Stock Option (right to buy) 0 Apr 2, 2025 Direct Common Stock

Transactions reported by Mark Neumann for Intra-Cellular Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.